Thomas Maddox, MD, MSc, vice president of Digital Products and Innovation for BJC HealthCare and a professor in the Cardiovascular Division, has been appointed to the inaugural FDA Digital Health Advisory Committee. The committee will advise the Commissioner of the Food and Drug Administration on digital health technologies (DHT’s) and guide on policies and regulations for their use. The first meeting was held in late November 2024 and focused on generative artificial intelligence (GenAI) and its use in healthcare.
Maddox Attends First FDA Digital Health Advisory Committee Meeting














































